Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept

BACKGROUND: Patient perceptions of treatment success, including satisfaction/preference, may complement clinical efficacy assessments. OBJECTIVE: Our objective was to evaluate satisfaction with subcutaneous golimumab and its auto-injector in patients with rheumatoid arthritis (RA) and an inadequate...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehoratius, Raphael J., Brent, Lawrence H., Curtis, Jeffrey R., Ellis, Lorie A, Tang, Kezhen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948248/
https://www.ncbi.nlm.nih.gov/pubmed/29427176
http://dx.doi.org/10.1007/s40271-018-0297-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948248/
https://www.ncbi.nlm.nih.gov/pubmed/29427176
http://dx.doi.org/10.1007/s40271-018-0297-5

Ejemplares similares